Global X Genomics & Biotechnology ETF (GNOM)
- Expense ratio0.47%
- Net assets$105.8M
- Dividend yield0.89%
- 1-year return+54.95%
- Holdings50
GNOM ETF price chart
GNOM quote & trading statistics
GNOM performance
Annual returns & drawdowns →- YTD+45.97%
- 1 year+54.95%
- 3 years+22.86%/yr
- 5 years-5.00%/yr
- 10 years0.00%/yr
- 1Y volatility
- 30.36%
- 3Y volatility
- 31.89%
- 3Y Sharpe ratio
- 0.60
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
GNOM top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | MRNA | Moderna Inc | 12.18% |
| 2 | TWST | Twist Bioscience Corp | 6.06% |
| 3 | TXG | 10X Genomics Inc | 5.99% |
| 4 | ILMN | Illumina Inc | 5.85% |
| 5 | NTRA | Natera Inc | 5.26% |
| 6 | GH | Guardant Health Inc | 5.01% |
| 7 | TECH | Bio-Techne Corp | 3.45% |
| 8 | 1548 | Genscript Biotech Corp | 3.45% |
| 9 | QGEN | Qiagen NV | 3.41% |
| 10 | VRTX | Vertex Pharmaceuticals Inc | 3.41% |
The top 10 holdings make up 54.1% of the fund (50 holdings in total). As of October 24, 2026.
About Global X Genomics & Biotechnology ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
GNOM ETF FAQ
What is the GNOM expense ratio?
Global X Genomics & Biotechnology ETF has a net expense ratio of 0.47%, or $47.00 a year for every $10,000 invested.
How much money is in GNOM?
Global X Genomics & Biotechnology ETF has about $105.8M in net assets.
What are the top holdings of GNOM?
The largest positions in GNOM are Moderna Inc (12.18%), Twist Bioscience Corp (6.06%), 10X Genomics Inc (5.99%). The fund holds 50 securities in total.
How has GNOM performed?
GNOM returned +54.95% over the past year and -5.00% a year over the past five years, including reinvested distributions.
Does GNOM pay dividends?
GNOM has a dividend yield of 0.89%.
When was GNOM launched?
Global X Genomics & Biotechnology ETF began trading on April 5, 2019.
ETFs similar to GNOM
Funds that track the same index or whose top-10 holdings overlap most with GNOM's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| GNOM | Global X Genomics & Biotechnology ETF | — | 0.47% | $105.8M | +54.95% |
| GNMX | Corgi Genomics & Precision Medicine ETF | 52% | — | — | — |